PPIs + Clarithromycin + Amoxicillin tablets bulk supplier for pharma manufacturers

Ppis + Clarithromycin + Amoxicillin Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: (PPI): 30 mg + Amoxicillin: 500 mg + Clarithromycin: 500 mg

Reference Brands: Prevpac(US)

PPIs bind to stomach H+/K+ ATPase enzymes, reducing acid secretion, creating a less hospitable environment for H. pylori. Clarithromycin and Amoxicillin target and eliminate the bacteria. The combination effectively eradicates H. pylori, relieves ulcers, and prevents gastric cancer. Benefits include symptom relief, mucosal healing, and reduced recurrence.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

PPIs combined with clarithromycin and amoxicillin tablets are approved in the US by the FDA and in the EU via EMA for Helicobacter pylori eradication. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports swift approval, safe use, and worldwide availability, helping healthcare providers effectively treat H. pylori infections and prevent gastric complications globally.

Ppis + Clarithromycin + Amoxicillin Tablets — third party manufacturing & bulk supply

Ppis + Clarithromycin + Amoxicillin Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ppis + Clarithromycin + Amoxicillin Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ppis + Clarithromycin + Amoxicillin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ppis + Clarithromycin + Amoxicillin Tabl... →

Back to Listing

Frequently Asked Questions

PPIs, clarithromycin, and amoxicillin are used in combination therapy for the eradication of Helicobacter pylori infection associated with peptic ulcer disease. This triple therapy helps reduce stomach acid, eliminate the bacteria, and promote healing of gastric and duodenal ulcers.

This therapy contains three components: a proton pump inhibitor (such as omeprazole, lansoprazole, or esomeprazole), clarithromycin, and amoxicillin trihydrate. The proton pump inhibitor reduces stomach acid production, while clarithromycin and amoxicillin act as antibiotics to kill Helicobacter pylori bacteria.

Common trade names for this triple therapy include Helidac, Omeclamox-Pak, and other H. pylori eradication therapy packs marketed by different pharmaceutical companies.

These combination therapy packs are produced by several pharmaceutical companies worldwide. For example, Omeclamox-Pak is marketed by Cumberland Pharmaceuticals, while other manufacturers also produce similar H. pylori treatment kits.

The generic components include a proton pump inhibitor (such as omeprazole, lansoprazole, or esomeprazole), clarithromycin, and amoxicillin trihydrate.

Brand names include Omeclamox-Pak, Helidac therapy pack, and other H. pylori eradication therapy kits marketed under different brand names.

These combination therapy packs are manufactured by multiple pharmaceutical companies in various regions, including the United States, Europe, India, and other global pharmaceutical manufacturing markets.